For example, Huo et al. predicted proteins FGG, SLC9A3, MAPK14, FGF1, FGB, F13A1, and CASR as potential therapeutic targets for the treatment of coronary heart disease (CHD) by combining the centrality-based and differentia-based approaches [30]. Here, F13A1 is linked to coronary artery disorder.